Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for lung cancer: targeted drug takes on chemo in Late-Stage trial

NCT ID NCT05089734

Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial compares a new targeted drug, sacituzumab govitecan, against the standard chemotherapy docetaxel in 603 people with advanced non-small cell lung cancer that has worsened after prior treatments. The main goal is to see if the new drug helps people live longer. The study is active but no longer recruiting participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sacituzumab govitecan (a targeted antibody-drug conjugate)
What this could lead to
If it works, this could offer a new treatment option for advanced lung cancer patients who have already tried chemotherapy and immunotherapy.
What could go wrong
This is a late-stage trial, but the drug may not prove better than the current standard docetaxel. Side effects from the antibody-drug conjugate can be serious.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

603 people

The number who actually took part.

Started

Nov 2021

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Pathologically documented non-small cell lung cancer (NSCLC) with documented evidence of Stage 4 NSCLC disease at the time of enrollment (based on the American Joint Committee on Cancer, Eighth Edition). * Epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and programmed death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) results are required. Testing prior to enrollment. Resulting for other actionable genomic alterations is recommended and to be performed as per local standard of care and availability of targeted treatment. For patients with squamous cell carcinoma, EGFR and ALK testing is optional. * Must have progressed after platinum-based chemotherapy in combination with anti-PD-1/PD-L1 antibody OR platinum-based chemotherapy and anti-PD-1/PD-L1 antibody (in either order) sequentially. * No additional treatments are allowed in the recurrent/metastatic setting for individuals with no actionable genomic alterations. * Individuals with EGFR, ALK, or any other known actionable genomic alterations must have also received treatment with at least 1 locally approved and available tyrosine kinase inhibitor 1(TKI) appropriate to the genomic alteration. * Documented radiographic disease progression while on or after receiving the most recent treatment regimen for advanced or metastatic NSCLC. * Measurable disease based on computed tomography (CT) or magnetic resonance imaging (MRI) as assessed by the investigator in accordance with per RECIST Version 1.1. * Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 before randomization. * Adequate hematologic counts without transfusional or growth factor support within 2 weeks of study drug initiation (hemoglobin ≥ 9 g/dL, absolute neutrophil count ≥ 1500/mm\^3, and platelets ≥ 100,000/μL). * Adequate hepatic function (bilirubin ≤ 1.5 x upper limit of normal (ULN), aspartate aminotransferase and alanine aminotransferase ≤ 2.5 ULN or ≤ 5 x ULN if known liver metastases, and serum albumin \> 3 g/dL). * Creatinine clearance of at least 30 mL/min as assessed by the Cockcroft-Gault equation. * Male individuals and female individuals of childbearing potential who engage in heterosexual intercourse must agree to use protocol-specified method(s) of contraception. Key Exclusion Criteria: * Mixed small-cell lung cancer and NSCLC histology. * Positive serum pregnancy test or women who are lactating. * Received a prior anticancer biologic agent within 4 weeks prior to enrollment or have received prior chemotherapy, targeted small molecule therapy, or radiation therapy within 2 weeks prior to enrollment and have not recovered (ie, \> Grade 2 is considered not recovered) from adverse events (AEs) at the time of study entry. Individuals participating in observational studies are eligible. * Have not recovered (ie, \> Grade 2 is considered not recovered) from AEs due to a previously administered agent. * Previously received treatment with any of the following: * Topoisomerase 1 inhibitors. Any agent including an antibody-drug conjugate (ADC) containing a chemotherapeutic agent targeting topoisomerase 1 * Trop-2-targeted therapy * Docetaxel as monotherapy or in combination with other agents * Active second malignancy * NSCLC that is eligible for definitive local therapy alone. * Clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses including, but not limited to, any underlying pulmonary disorder (ie, pulmonary emboli within 3 months of enrollment, severe asthma, severe chronic obstructive pulmonary disease, restrictive lung disease, pleural effusion, etc); any autoimmune, connective tissue, or inflammatory disorders with pulmonary involvement (ie, rheumatoid arthritis, Sjogren syndrome, sarcoidosis, etc); or prior pneumonectomy. * Known active central nervous system (CNS) metastases and/or carcinomatous meningitis. * Active cardiac disease * Active chronic inflammatory bowel disease (ulcerative colitis, Crohn's disease) or gastrointestinal perforation within 6 months of enrollment. * Active serious infection requiring antibiotics. * Positive HIV-1 or HIV-2 antibody with detectable viral load OR taking medications that may interfere with SN-38 metabolism. * Positive for hepatitis B surface antigen. Individuals who test positive for hepatitis B core antibody will require hepatitis B virus DNA by quantitative polymerase chain reaction for confirmation of active disease. * Positive hepatitis C antibody and detectable hepatitis C viral load. Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non small cell lung cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non small cell lung cancer

Contacts and locations

Locations

  • A Beneficência Portuguesa de São Paulo

    São Paulo, Brazil

  • AOU Policlinico G Rodlico-Oncologia Medica

    Catania, 95125, Italy

  • AOU mater Domini, UOC Oncologia Medica e Oncologia Medica Trazionale

    Catanzaro, 88100, Italy

  • APHP-Hopital Ambroise-Pare

    Boulogne-Billancourt, 92100, France

  • ASST Bergamo Ovest- ospedale di Treviglio-u.o. Oncologia

    Treviglio, 24047, Italy

  • ASST Cremona

    Cremona, 26100, Italy

  • ASST Grande Ospedale Metropolitano Niguarda SC Oncologia

    Milan, 20162, Italy

  • ASST Papa Giovanni XXIII, Oncologia Medica

    Bergamo, 24127, Italy

  • Acibadem Bursa Hastanesi

    Bursa, 16059, Turkey (Türkiye)

  • Acibadem Maslak Hastanesi

    Sariyer, Turkey (Türkiye)

  • Actualidad Basada en la Investigación del Cáncer

    Guadalajara, Mexico

  • Ad-Vance Medical Research, LLC

    Ponce, 00717, Puerto Rico

  • Alaska Oncology and Hematology, LLC.

    Anchorage, Alaska, 99508, United States

  • Algemeen Ziekenhuis Klina

    Brasschaat, 2930, Belgium

  • Algemeen Ziekenhuis Sint-Lucas

    Ghent, 9000, Belgium

  • Amphia Hospital

    Breda, 4818 CK, Netherlands

  • Ankara Sehir Hastanesi

    Dikimevi- Ankara, 06100, Turkey (Türkiye)

  • Asklepios Klinikum Harburg, Thoraxzentrum Hamburg - Lungenabteilung

    Hamburg, 21075, Germany

  • Asklepios-Fachkliniken Munchen-Gauting, Zentrum fur Pneumologie und Thoraxchirurgie

    Munchen-Gauting, 82131, Germany

  • Az Maria Middelares Ghent

    Ghent, 9000, Belgium

  • Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia

    Brescia, 25123, Italy

  • Bagcilar Medipol Mega Universite Hastanesi

    Istanbul, Turkey (Türkiye)

  • Baptist Clinical Research Institute

    Memphis, Tennessee, 38120, United States

  • Baptist Health Lexington

    Lexington, Kentucky, 40503, United States

  • Barts Health NHS Trust

    London, EC1A 7BE, United Kingdom

  • Beverly Hills Cancer Center

    Beverly Hills, California, 90211, United States

  • Border Medical Oncology Research Unit

    Albury, New South Wales, 2640, Australia

  • Box Hill Hospital

    Box Hill, Victoria, 3128, Australia

  • Broome Oncology, LLC

    Johnson City, New York, 13790, United States

  • CHITS-Hopital Sainte Musse

    Toulon, 83056, France

  • CHU Ambroise Pare

    Mons, 7000, Belgium

  • CHU de Bordeaux Hopital Haut leveque

    Pessac, 33600, France

  • CHU de CAEN

    Caen, 14033, France

  • CHU de Lille

    Lille, 59000, France

  • CHU de Poitiers

    Poitiers, 86021, France

  • CHU-Hopital Gabriel Montpied

    Clermont-Ferrand, 63000, France

  • CRIO - Centro Regional Integrado de Oncologia

    Fortaleza, 60810180, Brazil

  • Catatina Pesquisa Clinica - Clinica de Neoplasias Litoral

    Itajaí, 88331-10, Brazil

  • Centor Hospital of the National Center for Global Health and Medicine

    Shinjuku-Ku, 162-8655, Japan

  • Centre Francois Baclesse

    Calvados, 14076 CEDEX 05, France

  • Centre Hospitalier Annecy Genevois

    Epagny Metz-tessy, 74374, France

  • Centre Hospitalier Departemental Vendee

    La Roche-sur-Yon, 85925, France

  • Centre Hospitalier Intercommunal de Creteil

    Créteil, 94010, France

  • Centre Hospitalier Universitaire de Rouen - Hopitel Charles Nicolle

    Rouen, 76031, France

  • Centre Hospitalier de Chauny

    Chauny, 02300, France

  • Centre Hospitalier de la Côte Basque

    Bayonne, 64100, France

  • Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa

    Porto Alegre, 90110-270, Brazil

  • Centro Hospitalar Universitario do Porto

    Porto, 4099-001, Portugal

  • Centro Hospitalar Universitário Lisboa Norte - Hospital Pulido Valente

    Lisbon, 1769-001, Portugal

  • Centro de Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho

    Jaú, 17210080, Brazil

  • Centrum Medyczne Mrukmed

    Rzeszáw, 35-085, Poland

  • Chu Montpellier Hopital Arnaud de Villeneuve

    Montpellier, 34295 CEDEX, France

  • Clinica Universidad de Navarra-Pamplona

    Pamplona, 31008, Spain

  • Clinique Victor Hugo

    Le Mans, 72000, France

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200, Belgium

  • Complejo Hospitalario Universitario A Coruna. Hospital Teresa Herrera

    A Coruña, 15006, Spain

  • Comprehensive Cancer Centers of Nevada

    Henderson, Nevada, 89052, United States

  • Cryptex Investigación Clínica, S.A. de C.V.

    Mexico City, 06100, Mexico

  • East Suffolk and North Essex NHS Foundation Trust

    Colchester, CO4 5JL, United Kingdom

  • Elisabeth-TweeSteden Ziekenhuis (ETZ)

    Tilburg, 5022, Netherlands

  • Erasmus MC

    Rotterrdam, 3015, Netherlands

  • Euromedica General Clinic of Thessaloniki

    Thessaloniki, 54645, Greece

  • FirstHealth Outpatient Cancer Center

    Pinehurst, North Carolina, 28374, United States

  • Flinders Medical centre

    Bedford Park, South Australia, 5042, Australia

  • Florida Cancer Specialists

    St. Petersburg, Florida, 33705, United States

  • Florida Cancer Specialists

    West Palm Beach, Florida, 33401, United States

  • Florida Cancer Specialists (Administration and Drug Shipment)

    Fort Myers, Florida, 33901, United States

  • Fondazione IRCCS Policlinico San Matteo

    Pavia, 27100, Italy

  • Fondazione Policlinico Universitario Campus Bio-Medico, UOC Oncologia Medica

    Roma, 00128, Italy

  • Froedtert Hospital/Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Fukui Prefectural Hospital

    Fukui, 910-8526, Japan

  • Fundacao Champalimaud

    Lisbon, Portugal

  • GHR Sud Alsace - Hopital Emile Muller

    Mulhouse, 68100, France

  • Gallipoli Medical Research Foundation

    Greenslopes, Queensland, 4120, Australia

  • Gazi Universitesi Gazi Hastanesi

    Yenimahalle, Turkey (Türkiye)

  • General Hospital of Chest Diseases "I Sotiria", 3rd Internal Medicine Department of Athens University - Oncology Unit

    Athens, 11527, Greece

  • General Oncology Hospital of Kifisia "Agioi Anargyroi", 2nd Department of Medical Oncology

    Heraklion, Greece

  • General Oncology Hospital of Kifisia "Agioi Anargyroi", 2nd Department of Medical Oncology

    Nea Kifissia, 14565, Greece

  • Haaglanden Medical Centre

    The Hague, 2262BA, Netherlands

  • Hacettepe Üniversitesi Hastanesi

    Ankara, 06230, Turkey (Türkiye)

  • Hadassah University Hospital Ein Kerem

    Jerusalem, Israel

  • Henry Dunant Hospital Center, 4th Oncology Department

    Athens, 11526, Greece

  • Hiroshima University Hospital

    Hiroshima, 734-8551, Japan

  • Hopital Dupuytren (CHU de Limoges)

    Limoges, 87042, France

  • Hopital Foch

    Saint-Herblain, France

  • Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud

    Pierre-Bénite, 69495, France

  • Hospital CUF Porto

    Porto, 14341, Portugal

  • Hospital Clinical San Carlos

    Madrid, 28040, Spain

  • Hospital Clinicl universitario virgen de la Arrixaca

    Murcia, 30120, Spain

  • Hospital Regional Universitario de Malaga-Hospital Civil

    Málaga, 29010, Spain

  • Hospital San Pedro de Alcantara

    Cáceres, 10004, Spain

  • Hospital Universitari Dexeus

    Barcelona, 08028, Spain

  • Hospital Universitario 12 Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Cruces

    Barakaldo, 48903, Spain

  • Hospital Universitario Fundacion Jimenez Dias

    Madrid, 28020, Spain

  • Hospital Universitario Gregorio Marañón

    Madrid, 28007, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario Vall D'Hebron

    Barcelona, 08035, Spain

  • Hospital Universitario de la Princesa

    Madrid, 28006, Spain

  • Hospital Universitario la Fe

    Valencia, 46026, Spain

  • Hospital Virgen de Valme

    Seville, 41001, Spain

  • Hospital de Clínicas de Porto Alegre - HCPA

    Porto Alegre, 90035903, Brazil

  • Hospital de Sabadell

    Sabadell, 8208, Spain

  • Hospital universitario Virgen Macarena

    Seville, 41009, Spain

  • Hospital universitario la paz

    Madrid, 28046, Spain

  • Icon Cancer Centre

    Hobart, Tasmania, 7000, Australia

  • Illinois Cancer Specialists

    Niles, Illinois, 60714, United States

  • Institut Cancérologie Strasbourg Europe

    Strasbourg, 67033, France

  • Institut Catala D'Oncologia (ICO L'Hospitalet) Hospital Duran i Reynals

    Barcelona, 08908, Spain

  • Institut Catala d'Oncologia Badalona, ICO Badalona, Hospital Germans Trias i Pujol

    Badalona, 08916, Spain

  • Institut Catala d'Oncologia de Girona

    Girona, 17007, Spain

  • Institut Curie

    Paris, France

  • Institut Sainte Catherine

    Avignon, 84918, France

  • Institut de Cancérologie de l'Ouest - Paysde Loire (site SAINT HERBLAIN)

    Saint-Herblain, 44805, France

  • Instituto Europeo di Oncologia

    Milan, 20141, Italy

  • Instituto Portugues de Oncologia do Porto

    Porto, 4200-072, Portugal

  • Instituto Português de Oncologia de Coimbra Francisco Gentil

    Coimbra, 3000-075, Portugal

  • Instituto do Câncer do Estado de São Paulo "Octavio Frias de Oliveira" - ICESP

    São Paulo, Brazil

  • Instytut MSF Sp. z o.o.

    Lodz, 90-302, Poland

  • Interbalkan Medical Center of Thessaloniki

    Thessaloniki, 555 35, Greece

  • Japanese Red Cross Wakayama Medical Center

    Wakayama, 640-8558, Japan

  • Joondalup Health Campus

    Joondalup, Western Australia, 6027, Australia

  • Kagoshima University Hospital

    Kagoshima, 8908520, Japan

  • Kanagawa Cancer Center

    Yokohama, 241-8515, Japan

  • Kanagawa Prefectural Hospital Organization Kanagawa Cardiovascular and Respiratory Center

    Kanagawaken, 236-0051, Japan

  • Kanazawa University Hospital

    Kanazawa, 920-8641, Japan

  • Kansai Medical University Hospital

    Hirakata, 573-1191, Japan

  • Kansas City VA Medical Center

    Westwood, Kansas, 66205, United States

  • Kaplan Medical Center

    Rehovot, 76100, Israel

  • Kindai University Hospital

    Osakasayama-Shi, 589-8511, Japan

  • Klinik Floridsdorf, Karl Landsteiner Institute fur Lungenforschung und Pneumologische onkologie (LFPO) Abteilung Fur Innere Medizin un Pneumologie

    Vienna, 1210, Austria

  • Klinikum Esslingen GmbH Klinik fur Kardiologie,Angiologie und Pneumologie

    Esslingen am Neckar, 73730, Germany

  • Klinikum Kassel Klinik Für Hämatologie Onkologie Und Immunologie

    Kassel, 34125, Germany

  • Kobe City Medical Center General Hospital

    Hyōgo, 650-0047, Japan

  • Kurume University Hospital

    Kurume, 830-0011, Japan

  • Lahey Hospital & Medical Center

    Burlington, Massachusetts, 01805, United States

  • Leicester Royal Infirmary

    Leicester, LE1 5WW, United Kingdom

  • Levine Cancer Institute

    Charlotte, North Carolina, 28204, United States

  • Lungenfachklink Immenhausen

    Immenhausen, 34376, Germany

  • Maastricht Universitair Medisch Centrum

    Maastricht, 6229 HX, Netherlands

  • Maryland Oncology Hematology, P.A.

    Clinton, Maryland, 20735, United States

  • Marzowiecki Szpital Wojewodzki sw Jana Pawla II Wsiedicach sp. z.o.o Siedickie centrum onkoiogii

    Siedlce, 08-110, Poland

  • McGill University Health Centre

    Montreal, H4A 3J1, Canada

  • Medizinische Universität Innsbruck, Medizinische Universitat Innsbruck, Universitatsklinik fur Innere Medizin V, Hamatologie und Onkolgie

    Innsbruck, 06020, Austria

  • Memorial Ankara Hastane

    Ankara, 06520, Turkey (Türkiye)

  • Metropolitan General, Oncology department

    Cholargós, 15562, Greece

  • Miyagi Cancer Center

    Miyagi, 981-1293, Japan

  • Monash Health

    Clayton, Victoria, 3168, Australia

  • Muellner Hauptstrabe 48

    Salzburg, 5020, Austria

  • Nagasaki University Hospital

    Nagasaki, 852-8501, Japan

  • National Cancer Center Hospital

    Chūō, 104-0045, Japan

  • National Cancer Center Hospital East

    Kashiwa, 277-8577, Japan

  • National Hospital Organization Asahikawa Medical Center

    Asahikawa, 070-8644, Japan

  • National Hospital Organization Himeji Medical Center

    Hyōgo, 670-8520, Japan

  • National Hospital Organization Iwakuni Clinical Center

    Iwakuni, 740-8510, Japan

  • National Hospital Organization Kinki-Chuo Chest Medical Center

    Sakai, 591-8555, Japan

  • National Hospital Organization Nagoya Medical Center

    Nagoya, 460-0001, Japan

  • National Hospital Organization Osaka Toneyama Medical Center

    Toyonaka, 560-8552, Japan

  • Nebraska Hematology - Oncology

    Lincoln, Nebraska, 68506, United States

  • Niigata Cancer Center Hospital

    Niigata, 951-8566, Japan

  • Nippon Medical School Chiba Hokusoh Hospital

    Inzai, 270-1694, Japan

  • Nucleo de Pesquisa da Rede Sao Camilo-Instituto Brasileiro de controle do cancer-IBC

    São Paulo, 03102002, Brazil

  • ONCOSITE - Centro de Pesquisa Clinica em Oncologia

    Ijuí, 98700-000, Brazil

  • Okayama University Hospital

    Okayama, 700-8558, Japan

  • Onkologische Schwerpunktpraxis Heilbronn

    Heilbronn, 74245, Germany

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute

    Osaka, 541-8567, Japan

  • Pan American Center For Oncology Trials, LLC

    San Juan, PR, 00902, Puerto Rico

  • Panamerican Clinical Research S.A. de C.V

    Guadalajara, 44670, Mexico

  • Park Nicollet Frauenshuh Cancer Center

    Saint Paul, Minnesota, 55101, United States

  • Peninsula & South Eastern Haematology and Oncology Group

    Frankston, Victoria, 3199, Australia

  • Przychodnia Lekarska Komed Roman Karaszewski

    Konin, 62-500, Poland

  • Required Centre Hospitalier Regional de Rimouski

    Rimouski, G5L5T1, Canada

  • Rocky Mountain Cancer Centers - Aurora

    Aurora, Colorado, 80012, United States

  • Royal Victoria Regional Health Centre

    Barrie, L4M 6M2, Canada

  • SC Oncologia -ASST SETTE LAGHI

    Varese, 21100, Italy

  • Saitama Cancer Center

    Kitaadachi-gun, 362-0806, Japan

  • Samson Assuta Ashdod University Hospital

    Ashdod, 7747629, Israel

  • Sana Klinikum Offenbach, Medizinische Klinik IV fur Hamatologie und internistische Onkologie

    Offenbach, 63069, Germany

  • Senhora da Hora

    Matosinhos Municipality, 4464-513, Portugal

  • Shamir Medical Center (Assaf Harofeh)

    Tzrifin, Israel

  • Shenandoah Oncology Associates, PC

    Winchester, Virginia, 22601, United States

  • Shikoku Cancer Center

    Matsuyama, 791-0280, Japan

  • Shizuoka Cancer Center

    Sunto-gun, 411-8777, Japan

  • Siouxland Regional Cancer Center dba June E. Nylen Cancer Center

    Sioux City, Iowa, 51101, United States

  • Soroka Medical Center

    Beersheba, 84101, Israel

  • Southern Highlands Cancer Centre

    Bowral, New South Wales, 2576, Australia

  • St James University Hospital

    Leeds, LS9 7TF, United Kingdom

  • St Vincent's Public Hospital

    Darlinghurst, New South Wales, 2010, Australia

  • Stadtisches Klinikum Braunschweig gGmbH Medizinische Klinik III Hamatologie und Onkologie

    Braunschweig, 38114, Germany

  • Stony Brook Cancer Center

    Stony Brook, New York, 11794, United States

  • Studiengeselischaft Hamato-Onkologie Hamburg

    Hamburg, Germany

  • Sunshine Coast University Private Hospital

    Birtinya, Queensland, 4575, Australia

  • T.C. Saglik Bakanligi Goztepe Prof. Dr Suleyman Yalcin Sehir Hastanesi

    Kadıköy, Turkey (Türkiye)

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • Tennessee Oncology, PLLC

    Chattanooga, Tennessee, 37404, United States

  • Texas Oncology - Bedford

    Bedford, Texas, 76022, United States

  • Texas Oncology - Denison

    Denison, Texas, 75020, United States

  • Texas Oncology - Denton South

    Denton, Texas, 76201, United States

  • Texas Oncology - Paris

    Paris, Texas, 75460, United States

  • Texas Oncology Cancer Care and Research Center

    McAllen, Texas, 78503, United States

  • Texas Oncology-Plano East

    Plano, Texas, 75075, United States

  • Texas Oncology-Plano West

    Plano, Texas, 75093, United States

  • The Beatson West of Scotland Cancer Centre

    Glasgow, G12 0YN, United Kingdom

  • The Cancer Institute Hospital of JFCR

    Kōtō City, 135-8550, Japan

  • The Christie NHS Foundation

    Manchester, M20 4BX, United Kingdom

  • Tochigi Cancer Center

    Utsunomiya, 320-0834, Japan

  • Tottori University Hospital

    Yonago, 683-8504, Japan

  • Trakya Üniversitesi Sağlık Araştırma ve Uygulama Merkezi

    Edirne, Turkey (Türkiye)

  • UOC Oncologia

    San Giovanni Rotondo, 71013, Italy

  • USOR - Arizona Oncology Associates Tucson - Wilmot

    Tucson, Arizona, 85711, United States

  • USOR - Texas Oncology - McKinney

    McKinney, Texas, 75071, United States

  • Universitair Ziekenhuis Antwerpen

    Edegem, 2650, Belgium

  • Universitatsklinikum Schleswig-Holstein - Campus Lubeck, Medizinische Klinik III (Studienzentrum Pneumologie)

    Lübeck, 23538, Germany

  • University General Hospital of Larissa, Oncology Department-1St Internal Medical Division

    Larissa, 413 34, Greece

  • University Hospital Birmingham NHS Trust, Birmingham Heartlands Hospital

    Birmingham, B9 5SS, United Kingdom

  • University Hospital Kyoto Prefectural University of Medicine

    Kyoto, 602-8566, Japan

  • University Hospital Mannheim, Department of Personalized Medical Oncology with Section Thoracic Oncology

    Mannheim, 68167, Germany

  • University of Chicago Medical Center

    Chicago, Illinois, 60607, United States

  • University of Wisconsin Clinical Science Center

    Madison, Wisconsin, 53792, United States

  • W.G (Bill) Hefner VAMC

    Salisbury, North Carolina, 28144, United States

  • William Osler Health System-Brampton Civic Hospital

    Brampton, L6R 3J7, Canada

  • Windsor Regional Hospital Cancer Program

    Windsor, N8W 2X3, Canada

  • Woodlands Medical Specialists, PA

    Pensacola, Florida, 32503, United States

  • Yokohama Municipal Citizen's Hospital

    Yokohama, 221-0855, Japan

  • Zangmeister Cancer Center

    Columbus, Ohio, 43219, United States

  • ir Charles Gairdner Hospital

    Perth, Western Australia, 6009, Australia

  • zuniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU

    Salzburg, A-5020, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.